Hospital Mater DeiBSP:MATD3 -2.48%85 5-Year Yield-on-Cost % is 3.11 as of Jul. 02, 2026, which is 121% above its 10-year median of 1.41. GuruFocus rates BSP:MATD3 with a GF Score™ of 85/100 and a GF Value™ of R$5.86 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 282 Healthcare Providers & Services companies, Hospital Mater Dei ranks better than 54.26% on this metric.
Hospital Mater Dei's yield on cost for the quarter that ended in Mar. 2026 was 3.11.
The historical rank and industry rank for Hospital Mater Dei's 5-Year Yield-on-Cost % or its related term are showing as below:
BSP:MATD3'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.6 Med: 1.41 Max: 4.72
Current: 3.11
During the past 9 years, Hospital Mater Dei's highest Yield on Cost was 4.72. The lowest was 0.60. And the median was 1.41.
BSP:MATD3's 5-Year Yield-on-Cost % is ranked better than 54.26% of 282
companies
in the Healthcare Providers & Services industry
Industry Median: 2.87
vs BSP:MATD3: 3.11
Hospital Mater Dei (BSP:MATD3) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Hospital Mater Dei 5-Year Yield-on-Cost % Related Terms
BSP:MATD3 vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Hospital Mater Dei's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hospital Mater Dei 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hospital Mater Dei's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Hospital Mater Dei's 5-Year Yield-on-Cost % falls into.
Hospital Mater Dei 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Hospital Mater Dei (BSP:MATD3) has a 5-Year Yield-on-Cost % of 3.11 as of Jul. 02, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Hospital Mater Dei and its competitors. This is 121% above median its historical median of 1.41. Over the past decade, Hospital Mater Dei's 5-Year Yield-on-Cost % has ranged from 0.60 to 4.72. According to the industry distribution chart, Hospital Mater Dei ranks #129 out of 282 companies in the Healthcare Providers & Services industry, placing it in the top 45.7%.
Is Hospital Mater Dei's 5-Year Yield-on-Cost % too high?
Hospital Mater Dei's current 5-Year Yield-on-Cost % of 3.11 is 121% above median its 10-year median of 1.41. Over the past 10 years, this metric has ranged from a low of 0.60 to a high of 4.72. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.87. Hospital Mater Dei's value of 3.11 is 8.4% above this industry median. Based on the distribution chart, Hospital Mater Dei ranks #129 out of 282 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Hospital Mater Dei has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hospital Mater Dei's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Hospital Mater Dei ranks #129 out of 282 companies for 5-Year Yield-on-Cost %. This puts Hospital Mater Dei in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 2.87. Hospital Mater Dei's value of 3.11 is 8.4% above this benchmark. Historically, Hospital Mater Dei's own 5-Year Yield-on-Cost % has ranged from 0.60 to 4.72 over the past decade. While the company's 10-year median is 1.41 vs. the industry median of 2.87, Hospital Mater Dei has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.87, based on 282 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hospital Mater Dei's current 5-Year Yield-on-Cost % of 3.11 is 8.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Hospital Mater Dei and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hospital Mater Dei's current 5-Year Yield-on-Cost % is 3.11, which is 121% above median its own 10-year median of 1.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hospital Mater Dei stock overvalued right now?
Based on GuruFocus' analysis, Hospital Mater Dei (BSP:MATD3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$5.86, compared to a current price of R$4.72 — trading 19.5% below its estimated fair value. The current 5-Year Yield-on-Cost % is 3.11, which is 121% above median its 10-year median of 1.41 and 8.4% above the Healthcare Providers & Services industry median of 2.87. Hospital Mater Dei's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Hospital Mater Dei (BSP:MATD3), the current 5-Year Yield-on-Cost % is 3.11 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hospital Mater Dei (BSP:MATD3) Overvalued in 2026?
Based on GuruFocus' analysis, Hospital Mater Dei stock appears to be undervalued.
The current stock price of R$4.72 is trading 19.5% below its estimated GF Value™ of R$5.86.
GuruFocus considers Hospital Mater Dei to be Modestly Undervalued.
Key valuation signals for BSP:MATD3:
5-Year Yield-on-Cost %: 3.11 (121% above median its 10-year median of 1.41)
GF Value™: R$5.86 vs. price of R$4.72 (19.5% below fair value)
Industry Position: 8.4% above the Healthcare Providers & Services median (#129 of 282)
No single metric tells the full story. See the BSP:MATD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hospital Mater Dei SA is an integrated healthcare ecosystem that provides hospital and oncological services. The company provides a wide range of healthcare services, including hospitalizations, surgeries, oncology treatments, medical appointments, and diagnostic exams.
85GF Score
Get the complete analysis for BSP:MATD3
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:MATD3 has been successfully added to your 